A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/415 (2006.01)
Patent
CA 2179015
Disclosed is a method of inhibiting retroviral integrase in a subject in need of such treatment. The method comprises administering to the subject an effective retroviral integrase inhibiting amount of a bis-benzimidazole compound such as bis [5- amidino-2-benzimidazolyl] methane, 1,2-bis [5-amidino-2- benzimidazolyl] ethane, 1, 2-bis [5-amidino-2- benzimidazolyl] ethene or a pharmaceutically acceptable salt thereof. A method for combatting retroviral infections is also disclosed.
Procédé d'inhibition de l'intégrase rétrovirale chez un patient nécessitant un tel traitement, qui consite à administrer au patient une quantité efficace d'un composé bis-benzimidazole inhibant l'intégrase rétrovirale, tel que du bis[5-amidino-2-benzimidazolyl]méthane, du 1,2-bis-[5-amidino-2-benzimidazolyl]éthane, 1,2-bis[5-amidino-2-benzimidazolyl]éthène ou un sel pharmaceutiquement acceptable desdites substances. Un procédé de lutte contre les infections rétrovirales est également décrit.
Dykstra Christine C.
Swanstrom Ronald I.
Tidwell Richard R.
Sim & Mcburney
University Of North Carolina At Chapel Hill
LandOfFree
Use of bis(amidinobenzimidazoles) in the manufacture of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of bis(amidinobenzimidazoles) in the manufacture of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of bis(amidinobenzimidazoles) in the manufacture of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1784657